Targeting P23 by PM534 suppresses glioblastoma via disruption of SFPQ-mediated phase separation.
Glioblastoma (GBM) is one of the most lethal human malignancies, with a five-year survival rate of approximately 5% and limited effective therapeutic options beyond standard-of-care regimens, underscoring an urgent need for novel therapeutic agents and druggable targets. Here, we report that PM534, a marine sponge-deri...